 A total of sixty-eight 68 subjects were enrolled into the study, to be administered a single oral dose of the test or reference formulation of ramipril 10 mg capsule according to a randomization schedule. Two subjects subject numbers 01 and 06 were withdrawn from the study in period I and subject number 02 did not report for period II. 